Rishi Paliwal

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Nanomedicine (London, England)

Molecular pharmaceutics

Indira Gandhi National Tribal University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indira Gandhi National Tribal University Aug 21 2017

India

Assistant Professor :: Pharmacy

Siddhi Vinayaka Institute of Technology and Sciences Apr 24 2017 - Aug 19 2017

India

Associate Professor :: Pharmaceutics

Columbia Institute of Pharmacy Jul 02 2012 - Apr 22 2017

India

Associate Professor :: Pharmaceutics

Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy Dec 17 2013 - Dec 15 2014

United States

Post Doctoral Fellow

ISF College of Pharmacy Mar 17 2008 - Jun 28 2009

India

Assistant Professor :: Pharmaceutics

Globus College of Pharmacy Jun 10 2007 - Mar 15 2008

India

Lecturer (Assistant Professor) :: Pharmaceutics

Publications

Ankaj Kumar, Klaudi K Vaiphei, Naveen Singh, Sri Pada Datta Chigurupati, Shivani Rai Paliwal, Rishi Paliwal, Arvind Gulbake
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer. Nanomedicine (London, England) 19 (15) (2024)
Ankaj Kumar, Klaudi K Vaiphei, Naveen Singh, Sri Pada Datta Chigurupati, Shivani Rai Paliwal, Rishi Paliwal, Arvind Gulbake
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer. Nanomedicine (London, England) 19 (15) (2024)
Ankaj Kumar, Klaudi K Vaiphei, Naveen Singh, Sri Pada Datta Chigurupati, Shivani Rai Paliwal, Rishi Paliwal, Arvind Gulbake
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer. Nanomedicine (London, England) 19 (15) (2024)
Ankaj Kumar, Klaudi K Vaiphei, Naveen Singh, Sri Pada Datta Chigurupati, Shivani Rai Paliwal, Rishi Paliwal, Arvind Gulbake
Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer. Nanomedicine (London, England) 19 (15) (2024)
Balak Das Kurmi, Preeti Patel, Rishi Paliwal, Pramod Kumar, Shivani Rai Paliwal
Multifunctional nanotherapeutics for intracellular trafficking of doxorubicin against breast cancer. Nanomedicine (London, England) (2023)
Rishi Paliwal, Shivani R Paliwal, Govind P Agrawal, Suresh P Vyas
Correction to "Biomimetic Solid Lipid Nanoparticles for Oral Bioavailability Enhancement of Low Molecular Weight Heparin and Its Lipid Conjugates: In Vitro and in Vivo Evaluation". Molecular pharmaceutics 17 (6) (2020)

Rishi Paliwal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Rishi Paliwal